Taiwan FDA registration 2327a90ba8fa8620a08f1143e74dbf42
Abbott clinical amylase assay set
TW: 亞培臨床生化澱粉酶檢驗試劑組
Taiwan·Risk Class 2·ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.·Registered Dec 13, 2006 – Dec 13, 2026ActiveRegistration details
- Analysis ID
- 2327a90ba8fa8620a08f1143e74dbf42
- Customs Code
- DHA00601782803
Company information
- Manufacturer
- ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.
- Manufacturer Country
- Canada;;Germany
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- Quantitative analysis of Amylase in human serum, plasma or urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1070 澱粉酶試驗系統
- Import Information
- Contract manufacturing;; input
Dates and status
- Registration Date
- Dec 13, 2006
- Expiry Date
- Dec 13, 2026
About this record
Access comprehensive regulatory information for Abbott clinical amylase assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2327a90ba8fa8620a08f1143e74dbf42 and manufactured by ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices